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Sex Differences in Human Health and Disease
by

Matthew Robert Schwartz
B.S., University of New Mexico, 2010
M.S., University of New Mexico, 2019
PhD, University of New Mexico, 2020

ABSTRACT
Life history theory posits the evolution of sex-biased traits through asymmetries in the costs of
reproduction. The research presented here evaluated the downstream effects of sex-biases in
two age-related disease profiles: tooth loss, in which females exhibit a higher disease burden,
and melanoma, in which females have a survival advantage.
Among the Tsimane, a natural fertility population of forager-horticulturalists with a high lifetime fertility and no access to oral healthcare, females lose more than males and around half a
tooth per child. Parity accounts for 1.2% of variation in tooth loss within females, but no variation in tooth loss in males. We conclude that teeth are not a major cost of female reproduction
in Tsimane females.
Despite their poorer overall prognosis relative to females, late-stage and metastatic melanoma
tumors in males have a higher tumor mutational burden than females. Here we show this
relationship extends to early stage primary tumors. Males are likely to have high TMB when
compared to females, despite a poorer overall prognosis.
The two studies presented here will help us better understand the role of sex in melanoma and
tooth loss. They are important steps in towards a better understanding of the role of sex in
disease.
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Chapter 1
INTRODUCTION

Energy allocated in reproductive effort trades-off against the competing somatic demands of somatic maintenance and growth [133, 157, 156]. Over evolutionary time, these trade-offs led to organism and sex-specific biological life
history profiles[133, 120, 100, 1, 55] (1,2,5–10). Within humans, the costs of
reproduction are asymmetrical; gestation and lactation are energetically costly
and specific to females [31]. In addition to the energetic costs of gestation
and lactation, there is an immunological cost. During pregnancy the immune
system must be sufficiently suppressed to allow the antigenically distinct fetus
to grow without triggering an immune response that would terminate the fetus, but not so suppressed that the mother cannot fend off infections [97, 73].
One of the results of these female-specific constraints is a more robust and
plastic immune response. Females have stronger innate and adaptive immune
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responses and clear infections more efficiently than males [73]. Another is
the capacity to energetically buffer against the costs of reproduction through
the sequestration, allocation, and utilization of adipose tissue. Human females
have more peripheral fat, less visceral fat, and more overall adipose tissue than
males [146, 72, 110, 11]. Unsurprisingly, these sex-related asymmetries have
downstream consequences for disease and mortality. Males are more susceptible to infections, infections are more virulent in males, and males have higher
overall mortality compared to females [156, 15, 144].
While much of the sex-specific variation in morbidity and mortality are driven
by overlapping social determinants of health that fall along social relational
contexts blurred by gender, socioeconomic status, and education [117, 142, 90,
109], identifying these sex differences–sociocultural, biological, behavioral, or
otherwise–has large-scale implications for precision medicine and future research.
Accounting for the biological complexity underlying female-specific differences in immunocompetence and energy requires careful consideration in biomedical research conceptualization and design. Unfortunately, until recently this
complexity led studies to overlook, or purposely avoid, female-specific variation [151].
Older studies often failed to stratify for sex, or when they did, they lacked the
proper sample size to account for sex-specific variation [152, 76, 137, 154, 57,
2

23, 147, 7, 111, 39, 112, 94, 80, 71, 151]. The resulting “white-male white-rat”
biomedical paradigm implicitly uses male biology as the default and biases
research outcomes. The underrepresentation of female biology and behavior in
biomedical research has dangerous implications for clinical trials and precision
medicine.
This research evaluates sex-differences in health outcomes by evaluating two
diseases where sex-differences in immune function leads to sex-specific incidence and progression: 1) oral health, in which females exhibit a higher disease
burden, and 2) skin cancer, in which males exhibit a higher disease burden.
Females have higher rates of dental decay and tooth loss than do age-matched
males (39–45). These sex disparities in oral disease are pervasive and appear
historically in the fossil record and in living people worldwide. Parity is a
significant predictor of tooth loss (46–49). In populations receiving modern
dental care, the estimated dose response between children and lost teeth ranges
from half a tooth to more than a tooth per child [19, 125]. This effect remains
even after accounting for other significant predictors of tooth loss such as age,
smoking, and socioeconomic factors [19, 125, 123].
Our goal is to evaluate tooth loss as a potential cost of female reproduction in
a natural fertility population with little access to modern dentistry. We examine the relationship between parity and tooth loss in the Tsimane, a Bolivian
population in transition from a traditional subsistence economy to a modern
3

market economy. The Tsimane rarely use oral contraception, have high lifetime fertilities (Total Fertility Rate of 9 [51, 95]); their water is not artificially
fluoridated, and they have limited access to modern dentistry. The high fertility of the Tsimane creates a natural experiment to evaluate the relationship
between tooth loss and parity. This analysis is the first of its kind in size and
scope. Results from this analysis will help us better understand the complex
relationship between sex, reproduction, and tooth loss.
Unlike tooth loss, females have an advantage in melanoma outcomes when
compared to males [33, 115]. Females have a longer delay before relapse and
tumors are less likely to progress to lymph node or metastasize [66, 67, 127].
These differences follow a life history pattern with differences in melanoma
incidence and mortality peaking during reproductive years and decreasing with
age [33, 116]. As an immunogenic cancer, sex bias in immunocompetence
is one of the hypothesized pathways explaining this difference in melanoma
outcomes.
The immune system is especially critical to detecting and destroying melanoma
tumors. The recent development of successful alternatives to chemotherapy
such as immune checkpoint inhibitors and targeted therapies have dramatically
changed the treatment landscape for melanoma patients [34].
Tumor Mutational Burden (TMB), a count of the number of missense mutations
per megabase [16], is thought to be immune-related and is often used as a
4

biomarker of immunotherapy success. Patients with high TMB usually have a
better prognosis than patients with low TMB. Interestingly, among melanoma
patients, there is a sex specific pattern to TMB. Despite their poorer overall
prognosis relative to females, late-stage and metastatic tumors in males have a
TMB higher than females [121, 27]. Here we evaluate the relationship between
sex and Tumor Mutational Burden (TMB) in 288 AJCC 8th edition Stage IIAIIID primary tumors. This analysis is the first to investigate the relationship
between sex and tumor mutational burden in early-stage primary tumors that
have not received immunotherapy.
The results of this research adds to growing body of sex research. By evaluating these two diseases in which sex-differences in immune function leads
to sex-specific incidence and progression we add to our understanding of sex
differences in health outcomes. Here we uncover insights into the role of parity in tooth loss among the Tsimane. We also extend our understanding of the
relationship between sex and TMB from metastatic tumors to primary tumors
in early stage melanoma.
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Chapter 2
PARITY AND SEX IN TOOTH LOSS IN THE TSIMANE

2.1

Chapter Abstract

Objectives: To evaluate the effect of parity on tooth loss in a natural fertility
population with a subsistence economy.
Materials and Methods: The Tsimane are a natural fertility population of
Bolivia. Lifetime fertilities are high, water is not fluoridated, and access to
modern dentistry is minimal. Tooth pathology, tooth brushing, participant ages,
number of children, BMI, and route distance to the nearest market town were
measured as part of routine medical visits between June 2013 and July 2015.
We performed single regressions of tooth loss on parity and the four covariates.
Then we used multiple regression to evaluate the effect of parity on tooth loss
6

while controlling for covariates.
Results: The Tsimane have an extreme burden or oral disease. Tsimane women
have a substantially larger burden of tooth loss than do Tsimane men. Age, parity, and using a toothbrush are all statistically significant predictors of tooth loss
in both men and women. Neither BMI nor market integration were significant
in either sex. In women, the number of children accounted for 1.2% of the
variation (slope = 0.336, p = 0.004) when controlling for age and toothbrushing. The number of children fathered did not predict tooth loss in men when
controlling for age and toothbrushing (slope = -0.133, p = 1).
Discussion: After accounting for the effect of age and toothbrushing, the effect
of parity on tooth loss was robust and highly significant within women but not
in men. The proportion of variation in tooth loss explained by parity is small,
accounting for approximately 1.2% of the variation

2.2

Introduction

Women have higher rates of dental decay and tooth loss than age-matched men
[25, 26, 56, 91, 92, 124, 145]. These sex disparities in oral disease are pervasive
and appear historically in the fossil record and in living people worldwide.
Complex and interconnected biological factors related to pregnancy and childbearing are hypothesized drivers of much of the sex-specific variation in tooth
7

loss. Changes in hormonal profiles during pregnancy decrease salivary flow,
which reduces the buffering capacity of saliva and increases the risk of dental
caries and periodontal disease [28, 82, 81, 91, 92, 124, 135]. Both pathologies
increase the risk of tooth loss [125]. The same hormonal changes loosen the
cementum’s grip on the teeth and increase the likelihood of subgingival colonization by pathogenic bacteria [28, 82], which further increases the risk of
gingivitis and periodontitis. Moreover, pregnancy suppresses the immune system, reducing antimicrobial activity in the oral cavity, and creating an optimal
ecology for the proliferation of cariogenic bacteria [91]. These physiological
shifts are energetically and immunologically costly to women [31].
Because reproductive investments trade-off against competing physiological
demands, such as growth and maintenance, energetically costly pregnancies
should lead to a dose-dependent depletive effect in women but not men [64,
133]. Among the Tsimane while there is dose-dependent cost to weight, body
mass index (BMI), and body fat percentage with parity, it is not depletive.
Weight, body fat, and BMI increases with age. This increase eventually surpasses the costs incurred during reproduction, leading to a net gain over the life
course [51]. Unlike body fat, BMI, and weight, lost teeth cannot be recovered
and is a cumulative.
Parity is a significant predictor of tooth loss [19, 62, 106]. In populations receiving modern dental care, the estimated dose response between children and
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lost teeth ranges from half a tooth to more than a tooth per child [19, 125]. This
remains even after accounting for other significant predictors of tooth loss such
as age, smoking, and socioeconomic factors [19, 125].
Our goal is to evaluate tooth loss as a potential cost of female reproduction in a
natural fertility population with little access to modern dentistry. We examine
the relationship between parity and tooth loss in the Tsimane, a Bolivian population in transition from a traditional subsistence economy to a modern market
economy. The Tsimane rarely use oral contraception, have high lifetime fertilities (Total Fertility Rate of 9) [51, 95], their water is not artificially fluoridated,
and they have limited access to modern dentistry. We expect the high fertility of
the Tsimane creates a natural experiment to evaluate the relationship between
tooth loss and parity.
The Tsimane are a population of approximately 16,000 semi-sedentary foragerhorticulturalists living in over 85 communities spread across 12269km2 in the
Bolivian Amazon. The large population size and geographic expanse of the
Tsimane territory create a continuum in individual and community-level market
access and dietary composition.
The traditional Tsimane diet primarily consists of cultivated plant products,
such as rice, plantains, manioc, and corn; fish and lean meat; and fruits and
nuts gathered from the forest [79]. Tsimane also purchase market foods such
as noodles, sugar, and bread. The distance to the nearest market town largely af9

fects the accessibility of market foods. Some Tsimane communities are within
walking distance to the market town of San Borja (pop. 11,000). Road and
river access to the Tsimane communities has dramatically improved over the
past five years [54]. However, it still takes over 20 hours by motorized canoe
to reach San Borja from the most remote communities.

Community &
Market Integration

Dental Care

Parity

Tooth Loss

Health Damaging
Behaviors

Age & Sex

Figure 2.1: A conceptual model for the relationship between tooth loss and parity adapted from
Russel et al. [123]

To evaluate tooth loss as a possible biological cost of female reproduction in
the Tsimane, we use a theoretical model adapted from Russell et al (Figure 1).
Our adapted model focuses on the influence of the following four pathways on
tooth loss: Community and Market Integration, Health Damaging Behaviors,
Dental Care, and Parity

10

2.3
2.3.1

Materials and Methods
Data Collection and Study Variables

Examinations were conducted by Matthew Schwartz and Jaime Durbano between June 2013 and July 2015 as part of routine medical visits conducted
by the Tsimane Health and Life History Project (THLHP, www.unm.edu/ Tsimane ). Dental assessments were conducted in natural light setting, with a
mouth mirror, headlamp and probe with a 0.5 mm ball at the tip (Miltex WHO
(PSR) PROBE SE Model: 69-6319). The dental examination included verbally delivered questions on behaviors related to dental health, including tooth
brushing.
The level of pathology for individual teeth was coded on an ordinal scale with
five levels: 0 – healthy tooth with no visible evidence of caries, 1- visible
carious lesion smaller than 0.5 mm, 2- visible carious lesion in the enamel
larger than the 0.5mm, 3- only the root is remaining, and 4- missing. Each
tooth of the permanent dentition was scored except for third molars which were
left unscored due to agenesis.

11

2.3.2

Dental Care

Participants reported their use of tooth brushing and frequency of flossing during the interview. While toothbrushing is relatively rare, the Tsimane employ
a variety of tooth cleaning strategies including the use small sticks or plastic bags to remove food from their teeth. Of the 651 Tsimane that reported
cleaning their teeth the day of the assessment, 119 (10%) used a toothbrush or
toothpaste, 122 (10%) Tsimane used a finger to clean their teeth, 407 (36%)
used only water, and 3 used other (<1%). For our analysis, we coded individuals that reported using a toothbrush or tooth paste at least once in the past week
as ‘uses toothbrush’. At the end of the assessment participants were given a
toothbrush and instructions in its use. Although the Tsimane do not have regular access to a dentist, itinerant ‘dental mechanics’ pull teeth for an affordable
price. These dental mechanics visit communities at least yearly.

2.3.3

Community and Market Integration

The large geographic expanse of the Tsimane creates a well-established continuum of market integration; distance to market is a proxy of this communitylevel market integration [54, 86, 126]. We include two proxy markers of socioeconomic position, the travel distance to market town and BMI. The total travel
distance between the market town of San Borja and each Tsimane community
was measured with handheld global positioning devices.
12

Agustina Bani, the Tsimane Health and Life History Project (THLHP) medical
assistant measured height and weight using a Seca Portable stadiometer (Road
Rod 214) and Tanita Scale and Body Fat Monitor (BF680). We calculated BMI
from these measurements as mass (kilograms) divided by the square of height
(meters). BMI over 30 indicates obesity.

2.3.4

Health Damaging Behaviors

Among the Tsimane, smoking and the consumption of alcohol–well-known
risk factors of tooth loss–is minimal and largely limited to men [43, 42, 53].
Men also chew the coca leaf, a mild stimulant commonly used across Bolivia.
When ‘chewing’ coca, the leaves are packed into the cheek and left for extended
periods of time. Baking soda is often used with the leaves to enhance the its
effect. Baking soda is protective against caries and is a cost-effective alternative
to commercial toothpaste [93, 113]. Although dental care is not the intended
use of baking soda.
Tsimane women make chicha, a homemade beverage made by masticating
boiled manioc root and allowing it to ferment. They often prepare chicha together and begin at a young age. Preparing soft foods in this manner is conducive to bacterial growth and leads to dental decay.
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2.3.5

Parity

Participant ages were determined by written records, relative age lists, dated
events, photo comparisons of people with known ages. All age estimates are
cross-checked with information from independent interviews of kin, as described by Gurven and colleagues (MG, HK) [52] . Reproductive histories
were recorded for both women and men from self-reports during interviews.
Parity was measured by the number of children a woman bore. Fertility was
measured for each man as the total children fathered.

2.3.6

Statistical Methods

We used the total missing teeth (TMT), summed over the adult dentition (excluding third molars), as a composite measure of tooth loss for individuals. The
potential range for this variable is from zero to 28. We conducted single regressions of TMT on parity and four potential covariates: age, tooth brushing, distance from market place, and body mass index. Because tooth loss is not continuous, and the error terms are not normally distributed with equal variance at
all levels of the predictors, we use permutation tests to avoid inflating the probability of type-I error in hypothesis tests. In brief, our permutation tests had the
following structure for single regression analyses. Step 1. We computed the
regression of our outcome variable (TMT) on a predictor variable (e.g., parity
or a covariate) using the observed data and stored the regression coefficient.
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Step 2. For each individual, we matched the value of the outcome variable
with the value of the predictor variable from an individual sampled randomly
without replacement from the entire data set. We recomputed a regression for
the permuted data and stored the regression coefficient. Step 3. We repeated
Step 2 10,000 times to obtain the permutation distribution for the regression
coefficient. Step 4. We computed the empirical p-value as the proportion of
the permuted regression coefficients that were more deviant from zero than our
observed value. Such tests are powerful and distribution free [44].
We performed a multiple regression to test whether parity was a significant
predictor of TMT while controlling for the effects of significant covariates.
We used a permutation method to test for statistical significance of the partial
regression coefficient. This test relies on a well-known property of multiple
regression analysis. In a multiple regression of an outcome Y on a set of predictors X1 , X2 , · · · Xp , the slope of Y on a chosen predictor (say X1 ) is the
single regression of Y on the residuals of X1 regressed on the remaining predictors X2 · · · Xp [132]. Thus, we regressed parity on the remaining covariates,
and then applied the permutation method described above to regression of TMT
on the residuals.
We performed the single and multiple regression analyses described above separately on women and men.
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2.3.7

Human Subjects

All methods and procedures were approved by the Institutional Review Boards
of University of California, Santa Barbara (UCSB: #12–496) and University
of New Mexico (UNM: #07–157). Informed consent was given by the Tsimane governing body, Gran Consejo Tsimane, the local village leaders, and by
individual study participants.

2.4

Results

Our total sample includes 1125 individuals over the age of 15: 608 females and
517 males. Table 2.1 provides sample characteristics and descriptive statistics.
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Table 2.1: Sample composition of Tsimane: 2013 - 2015

N
Age Categories (%)
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Age (median [IQR])
Parity groups (%)
0-2
3-4
5-7
8+
Parity (median [IQR])
Missing teeth (median [IQR])
DMFT (median [IQR])
Uses toothbrush (%)
BMI (median [IQR])
Distance to market

Males
517

Females
608

110 (21.3)
70 (13.5)
73 (14.1)
60 (11.6)
38 (7.4)
39 (7.5)
38 (7.4)
89 (17.2)
30 [21,44]

145 (23.8)
98 (16.1)
107 (17.6)
59 (9.7)
54 (8.9)
44 (7.2)
40 (6.6)
61 (10.0)
27 [20,39]

276 (53.4)
68 (13.2)
76 (14.7)
97 (18.8)
2.00 [0.0, 6.0]
5.0 [2.0, 11.0]
19 [12, 27]
163 (31.5)
22.5 [21, 24]
43.2 [25.5, 55]

294 (48.4)
95 (15.6)
99 (16.3)
120 (19.7)
3.00 [0.0, 7.0]
8 [3.0, 17]
19 [13, 27]
141 (23.2)
22.88 [21, 25]
34.78 [25.5, 55]

Figure 2.2 presents the data in detail. Each horizontal row corresponds to one
participant and each column corresponds to one tooth type. The rows are ordered by age and the shading shows the severity of dental pathology. There is
a high level of tooth loss and dental pathology overall. The pattern of pathology varies between the maxilla and the mandible and between the anterior and
posterior dentition. The extent of pathology rises with age and in across the
dentition. The canines are the least affected tooth category. In females, there
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is high pathology across the entire maxillary dentition. Incisors show a striking early onset of pathology. In males, the pattern is similar albeit attenuated.
Compared to females, incisors in the male mandible are healthier and there is
more pathology in molars. These data show that tooth loss and age are highly
related. We can expect that age will confound the relationship between tooth
loss and parity, as parity also increases with age.
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Women (n=633)

Men (n=543)

Upper Teeth

Molars Premolars Canine

Incisors

Upper Teeth

Molars Premolars Canine

Canine Premolars Molars

Incisors

Canine Premolars Molars

15-24

15-24

25-34

25-34

35-44
35-44
45-54
45-54
55-64
55-64
65+
65+

15-24

15-24

25-34

25-34

35-44
35-44
45-54
45-54
55-64
55-64
65+
65+

2nd

1st

2nd 1st

Lateral Central Lateral

1st

2nd 1st

2nd

2nd

Lower Teeth

1st

2nd 1st

Lateral Central Lateral

1st

2nd 1st

2nd

Lower Teeth

0 - Healthy
1 - Superficial cavity
2 - Deep cavity
3 - Only root is left
4 - Missing tooth

Figure 2.2: Tsimane Oral Health Status. The health status form all sampled individuals measured
on a five-point scale from healthy to missing. Each column represents a tooth type. Rows are
individuals sorted by age.

Single regression analysis (Table 2.2), using the permutation test, shows that
age, parity, and using a toothbrush are all statistically significant predictors of
19

tooth loss in both males and females. Age explains the highest percentage of
variation in tooth loss: 58% and 42%, respectively. Parity explains 41% of the
variation in tooth loss with females and 15% in males. Using a tooth brush
explains a relatively small percentage of variation: 3% in males vs 3.3% in
females.
Neither BMI nor distance to market accounted for any significant proportion of
variation in tooth loss in males or females.
Table 2.2: Single regression of tooth loss on potential covariates

Women
Slope
r2
Age
0.460
0.583
Parity
1.330
0.415
Uses toothbrush
-3.533 0.033
BMI
0.003
0.001
Distance to market 0.009
0.000

p − value∗
0.000
0.000
0.000
0.427
0.607

Men
Slope
r2
p − value
0.262 0.424
0.000
0.571 0.150
0.000
-2.341 0.030
0.000
-0.003 0.001
0.458
-0.020 0.004
0.160

Table 2.3: Multiple regression of tooth loss on children, age, and toothbrushing

Age

Children

Uses Toothbrush

Women
Slope
Sum of Squares
Variation explained (Partial correlation
p-value

0.380
23,721.7
0.418
0.000

0.336
489.1
0.108
0.004

-1.461
226.6
-0.075
0.032

Men
Slope
Sum of Squares
Variation explained (%)
Partial correlation
p-value

0.281
8,531.4
42.4
0.519
0.000

-0.133
79.8
0.4
-0.067
1.00

-0.979
103.7
0.032
-0.072
0.053
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To confirm that child-bearing influences tooth loss in women independent of
tooth brushing and age, we performed a multiple regression of tooth loss on
parity with age and tooth brushing serving as covariates (Table 2.3). In this
model the number of children explained a small portion of variation in the
number of missing teeth, r2 = 0.012 with empirical p = 0.004. A parallel
analysis conducted on males did not find an association between tooth loss and
the number of children fathered, r2 = 0.004 with empirical p = 1.000.
Table 2.4: Multiple regression of tooth loss on children, age, and toothbrushing, interaction model

Sex (Women)
Age
Number of Children
Brushes teeth
Sex×Age (Women)
Sex×Children(Women)
Constant
Observations
R2
Adjusted R2
Residual Std. Error
F Statistic

Number of Missing Teeth
b (95% CI)
-0.956
(-2.479, 0.568)
∗∗∗
0.281
(0.244, 0.319)
-0.135∗
(-0.271, 0.001)
-1.118∗∗∗ (-1.783, -0.453)
0.101∗∗∗
(0.043, 0.158)
0.472∗∗∗
(0.269, 0.674)
∗∗∗
-1.643
(-2.767, -0.518)
1,125
0.564
0.562
4.975 (df = 1118)
241.151∗∗∗ (df = 6; 1118)

Regression results in Table 2.4 show that while the main effect of sex is not significant (: −0.956, 95% CI [−2.479, 0.568]), there are significant interactions
of age by sex and parity by sex.
Those interactions indicate that at least in the cross-section, women lose teeth
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more rapidly than men as they age and that parity has a much stronger effect on
tooth loss among women than men. Tsimane women lose 0.1 additional teeth
lost per year, and 0.47 more teeth per child, respectively, than men. For men,
having more children was actually associated with slightly lower rates of tooth
loss, although this effect is not significant. Tooth brushing is associated with
lower tooth loss overall in the full model for both sexes.

15
10
5

Women
Men
0

Number of Missing Teeth

20

25

Total tooth loss by age holding parity and tooth brushing at the mean
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30

40

50

60

70

80

Age
Figure 2.3: Counterfactual plot of tooth loss by age, holding parity and tooth brushing at the mean.
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15
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5

Number of Missing Teeth
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Total tooth loss by parity holding age at 50 and tooth brushing at the mean
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Men

0

5
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15

Number of Children
Figure 2.4: Counterfactual plot of tooth loss by parity, holding age at 50 and tooth brushing at the
mean.

2.5

Discussion

After accounting for the effects of age and toothbrushing, the effect of parity on
tooth loss was statistically significant in women. Unexpectedly, the proportion
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of variation in tooth loss explained by parity is small. By contrast, the number
of children fathered was not a statistically significant predictor of tooth loss in
men. This sex difference supports the hypothesis that pregnancy, parity, and
raising children interconnect and have biological consequences for a woman’s
health. An unanticipated, but important finding of this study is the high frequency of tooth loss in Tsimane women and men. The higher rate of tooth loss
in Tsimane women is consistent with many other studies, but the reasons for
it are obscure. In the following paragraphs we will review and interpret our
findings using the main components of our theoretical model (Figure 2.1).

2.5.1

Community and Market Integration

Socioeconomic measures, including family income, education, and occupation, predicted tooth loss in a study of data from the Third National Health
and Nutrition Examination Survey (NHANES III) in the United States. These
variables are not relevant to, and cannot be measured for, the Tsimane. However, the Tsimane vary in relation to the degree they have transitioned from a
subsistence economy to a market economy. We used two measures of market
integration for this study: distance from a community to the nearest market
town, and BMI. Neither marker of economic transition predicted tooth loss in
our data. However, men are more likely than women to engage in paid work
such as logging, ranching, and mining, and accordingly men are more market
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integrated than are women.

2.5.2

Health Damaging Behaviors

The Tsimane engage in several dental health–damaging behaviors, including
smoking, eating cariogenic foods, drinking commercial and indigenous alcoholic beverages, preparing chicha, and chewing coca leaves. It is interesting
these behaviors are skewed between the sexes. Women exclusively produce
chicha, which exposes their teeth to the cariogenic starches. The Tsimane men
chew coca leaves, and are more likely than women to smoke or consume alcohol.

2.5.3

Dental Care

The Tsimane employ a variety of traditional and modern methods of dental
care, including flossing, rinsing, and picking. A substantial portion of Tsimane
have used a commercial tooth brush at least one time in the past week (Table
1). More men than women have used a commercial tooth brush (32% versus
23%) which may be enabled through their wage labor, which brings them to
market communities. Having decayed teeth removed by ‘dental mechanics’ is
a particularly noteworthy practice, because the mechanics predominantly serve
women. Moreover, the mechanics visit Tsimane communities often, at least
yearly. Any tendency for the mechanics to prematurely pull teeth will con25

tribute to the female bias in missing teeth. Our data hint at such tendency.
Table 1 shows that women have more missing teeth than men do (8 versus 5).
However, the proportion of decayed and missing teeth (DMFT) is the same between men and women (19 in each). A possible reason for this discrepancy
is that men carry decaying teeth longer than women do. The early removal of
decaying teeth by dental mechanics would produce this pattern. It is also possible that over-zealous pulling of teeth would overpower the usual relationship
between parity and tooth loss.
Our data identify the Tsimane environment as generally unfavorable to oral
health. This is likely to have long-term consequences for the Tsimane as they
become more immersed in a market economy. A recent paper has described
the Tsimane as having the ‘healthiest hearts in the world’; the Tsimane have
excellent overall cardiovascular health across age and sex, with virtually no
cardiovascular disease (CVD)(Kaplan et al., 2017). However, tooth loss is a
predictor of both CVD and CVD-associated mortality (Holmlund, Holm, &
Lind, 2010; Jansson, Lavstedt, Frithiof, & Theobald, 2001; Joshipura et al.,
1996; Meurman, Sanz, & Janket, 2004; Montebugnoli et al., 2004; Paunio,
Impivaara, Tiekso, & Mäki, 1993). An emerging literature proposes tooth loss
and overall oral health as upstream predictors of future cardiometabolic disease. If correct, the Tsimane are facing an impending health crisis. Future
studies should include a multi-level health interventions and assessments of
cardiometabolic markers.
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This is the first large-scale study of tooth loss in the Tsimane and is the first
to evaluate tooth loss and parity in a large sample of natural fertility foragerhorticulturists. While Tsimane across age and sex have an extreme burden of
dental pathology, the schedule of loss is accelerated within Tsimane females.
As hypothesized, we found that after accounting for the effect of age and toothbrushing, the number of children increases tooth loss within Tsimane females
but not Tsimane males. However, the effect is small, accounting for approximately 1.2% of the variation in tooth loss. Because the extreme tooth loss
across age and sex and because parity accounts for a little variation in tooth
loss, we conclude that among the Tsimane teeth are not a major cost of female
reproduction. It appears that other factors overwhelm parity in their effects on
tooth loss in Tsimane women.
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Chapter 3
SEX DIFFERENCES IN MELANOMA

3.1

Chapter Abstract

Purpose of Review: The goal of this review has been to elucidate the sex
differences in cancer incidence and mortality in cutaneous melanoma. We have
evaluated biological and behavioral research to determine where the critical
questions exist.
Recent Findings: The most recent findings are exploratory in nature but seem
to indicate that the differences are more likely due to biological variations
rather than behavioral. While behavioral studies do show that women are more
likely than men to seek health care and practice healthy behaviors, these differences are not sufficiently strong to explain the variation in incidence and
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mortality in cutaneous melanoma. Evolved differences in the immune systems
of females and the role of sex steroid hormones in immunomodulation are two
promising avenues for research. Studies in mice demonstrate that the newer
immunotherapies are more effective in females and sex steroid hormones, such
as estrogen receptor beta are inversely associated with tumor aggressiveness
while testosterone increases it.
Summary: Our analysis indicates that biological factors need to be investigated more thoroughly to understand the variation in incidence and mortality
in cutaneous melanoma. Such understanding could lead to reducing incidence
and mortality for both males and females. It is most likely that behavioral
differences between the sexes cannot account for the preponderance of male
mortality. In addition to the important role of genetic factors, it is critical to
evaluate further additional biological factors and their interactions with genetics and behavior.

3.2

Introduction

Sex differences in cancer incidence and mortality are robust, consistent, and
well-documented; men have a higher risk of developing cancer and one-anda-half times the risk of mortality [102]. This increased risk cuts across racial
and ethnic groups and all cancer types [21, 22, 24, 129]. Although melanoma
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incidence over the last five years has increased for both sexes (1.2% for females and 2.3% for males), the good news is that mortality from melanoma has
decreased by 2.8% for females and 3.0% for males [24].
In terms of sex differences in survival from cancer, cutaneous melanoma is one
of the most striking [22]. Women retain a 38% survival advantage compared
to men after adjusting for stage at diagnosis [67, 65, 66, 115]. When compared
to men, women have thinner tumors, less tumor ulceration, less progression to
lymph node or organ metastases, a longer delay before relapse, and a higher
cure rate [67, 66, 128].
Here we summarize the sex differences in melanoma, covering the spectrum
from biologically-based pathways with immunological, hormonal, and genetic
underpinnings, to behavioral-related pathways such as differences in UV exposure, primary care access, and skin awareness.

3.2.1

Immunity

Sex-specific differences in overall immune function are robust and well-documented.
Women mount more effective cellular and humoral immune responses and are
less likely to succumb to bacterial and viral infections than men [2, 12, 74, 73].
Life history theory attributes these differences to sex-specific evolutionary tradeoffs in energetic allocation to competing somatic demands such as reproduction

30

[133, 157, 156]. One notable example of sex-specific reproductive asymmetry
is the nine-month period of pregnancy. The mother’s immune system must
be sufficiently suppressed through a complex interplay between energetics, immune cells, and hormones to allow the antigenically distinct fetus to grow without triggering an immune response, but not so suppressed that the mother cannot fend off infections [97]. Over evolutionary time, such asymmetries have
led to sexually dimorphic systems such as immunity.
As an immunogenic disease, the immune system is especially critical to detecting and destroying melanoma tumors. For this reason, alterations to the
immune system such as systemic immunosuppression after a major organ transplant, are major risk factors for the development of melanoma [118]. In order to
evade detection by the immune system, melanoma tumors down-regulate surface antigens, and secrete immunosuppressive cytokines in the tumor microenvironment, effectively suppressing the site-specific immune response [6, 96].
If successful, malignant melanomas evade detection and spread throughout
the body and into the lymphatic system, further compromising host immunity
[153].
Melanoma, like many tumors, is chemoresistant, making previous treatments
difficult and often ineffective. Fortunately, the recent development of successful alternatives to chemotherapy such as immune checkpoint inhibitors
and targeted therapies are dramatically changing the treatment landscape for

31

melanoma patients [34]. Interestingly, in mice, immune checkpoint inhibitors
are significantly more effective in women than men [88]. Whether this is true
for humans will await the results of further trials.

3.2.2

Endocrine Factors

Other sex-specific immune-modulating factors such as steroid hormones like
estrogen and testosterone have been heavily implicated in host immune activation and response [10, 35, 41, 48, 49, 78, 89, 139, 148, 150], largely through
sex-steroid receptors located on immune cells (Jung et al., 2012; Micheli et
al., 2009; Shang, 2007). Estrogen acts as a powerful immune- enhancer, potentiating antibody [12] and likely inflammatory responses (Barzi et al., 2013;
Caiazza et al., 2015; Y. Yang & Kozloski, 2011). Testosterone on the other
hand, attenuates non-specific immune response [12].
The role of sex steroid hormones in melanoma is far from clear (Nosrati &
Wei, 2014). The expression of the estrogen receptor beta (ER-β) is negatively
associated with melanoma invasiveness and tumor thickness (V. de Giorgi et
al., 2013). The exogenous addition of estrogen inhibits tumor growth in vitro
(Kanda & Tamaki, 1999) and in metastatic tumors (Vincenzo de Giorgi et al.,
2009), while testosterone increases tumor aggressiveness [103] (Shahabi et al.,
2013).
Reproductive status such as pregnancy and menopause have large within-sex
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differences in fluctuating sex-steroid hormones, conveniently presenting researchers with natural experimental conditions. Reproductive-age women have
a more reactive inflammatory profile (Gubbels Bupp et al., 2018) and higher
levels of T-lymphocytes when compared to post-menopausal women [12] (Giglio
et al., 1994; J. H. Yang et al., 2000). There appears to be no association between pregnancy and melanoma (Nosrati & Wei, 2014). The relationship between menopause and melanoma survival is conflicted, multiple studies have
found no evidence of differences in post-menopausal groups [66, 70, 83], while
others have documented significant differences in post-menopausal groups [67,
18, 27, 99, 134] (Måsbäck et al., 2001).

3.2.3

Genetic Factors

Phenotypic differences in both immunocompetence and steroid hormones are
largely driven by differences in underlying genetic architecture. Until recently,
the cost of genetic sequencing has been a major barrier to genomic research.
However, decreasing sequencing costs has greatly increased the capacity to
study the genotypic features of melanoma.
Several genetic factors are suggested as underlying a male survival disadvantage in melanoma outcome. The X chromosome alone has 1,500 genes containing oncogenes and tumor suppressor genes whose regulation are critical to
cancer progression and suppression compared to the 344 genes on the Y chro33

mosome [103]. Additionally, men carry the potential deleterious effects of X
chromosome monosomy and oncogenes on the Y chromosome (TSPY) [103].
Differences in autosomal genetic variations are important in understanding the
mechanisms of sex disparity in melanoma. Previous studies have reported significant differential genetic effects for melanoma by sex. A non-synonymous
single nucleotide polymorphism (SNP), rs16891982, in the SLC45A2 gene is
shown to be associated with much higher risk for melanoma in males (OR=5.5
in males vs OR=2.37 in females) [75]. A study of melanoma in a Spanish population discovered that SNPs relating to pigmentation constitutes one potential
genetic cause underlying a higher rate for melanoma in males [59]. SNPs in
genes (TYR, GPR143, and F2RL1) were shown to increase melanoma predisposition in males as opposed to females, and these SNPs were also found
to be associated with dark pigmentation and sun tolerance in females but not
in males [59]. A recent study reported that sex differences in outcomes of
cutaneous melanoma patients were associated with inherited abnormalities on
TP53, MDM2 and BCL2 genes in the apoptosis pathway [104]. The MC1R red
hair variants were demonstrated to contribute differentially to melanoma risks
in males and females [149].
Melanoma has a high rate of missense mutations [50]. These antigenic mutations increase the likelihood of detection by the immune system [50]. Patients with these high tumor mutational burdens (TMB) have lower mortality
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rates [45, 131] and greater prognosis with immunotherapy. Counterintuitively,
Gupta et al. reported a higher burden of somatic missense mutations among
men (median of 298) compared to women (median of 211.5) using data from
266 metastatic melanomas from The Cancer Genome Atlas (TCGA) project
[50], despite a higher overall male mortality.
While driver mutations in BRAF [5, 114, 140], NRAS [140], and KIT [77] are
essential in the development and progression of melanoma, very few studies
have observed evidence of differential mutations between males and females
for these important genes [36, 85, 140] warranting future larger studies performing comprehensive assessments of sex differences in driver mutations.
X-linked genes have been implicated in sex differences in melanoma outcome.
The PPP2R3B gene, located on the X chromosome in females and the Y chromosome in males, was reported to have lower expression in males than in females and was independently associated with poor melanoma outcome [143].
Autosomal gene expression levels differ between males and females and may
also play an important role in exploring the mechanisms for the sex disparity
in melanoma [29, 103]. The miR-221&222 and miR-506-514 clusters, which
could be related to sex differences, were demonstrated to have oncogenic roles
in melanoma progression and melanocyte transform [32, 136]. In addition, long
non-coding RNAs are emerging as important modulators of melanoma proliferation, survival and metastatic behavior, which have the potential to be used
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as novel prognostic and diagnostic markers and contribute to understanding the
sex differences in melanoma [73, 87].

3.2.4

Behavioral Factors

The continued increase in melanoma-specific cancer incidence is often thought
to be the result of a combination of increased detection (possibly over-diagnosis)
and exposures such as tanning bed use and harmful recreational UV exposure
(Jemal et al., 2011). However, while women are more likely to use a tanning
(Boldeman et al., 1997; Fears et al., 2011; Group, 2012; Schneider et al., 2013),
the risk for melanoma from using tanning beds is similar for each sex (DeAnn
Lazovich et al., 2010).

3.2.5

Health Behavior

One of the hypothesized causes of the increased incidence and later tumor
stages at the time of diagnosis among men is the fact that men are less likely to
go to the doctor [20, 37, 119] or find a tumor until it has grown deeper, while
women tend to attend clinics and utilize more primary care than men [14, 20].
Skin awareness, skin self-examination and physician examination are all associated with the discovery of thinner lesions by both men and women [138].
However, females are more likely to be aware of their skin and to conduct skin
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self-screening as well as visit physicians for health reasons.
Paddock et al found that in women the practice of routine skin self-examination
increased the likelihood that the lesion would be self-discovered; females were
significantly more likely to conduct skin self-examination than males (58.1 percent vs 41.9 percent, p = 0.03) [107]. “Skin awareness” (that is, being aware
of one’s skin for medical or cosmetic reasons) was associated with a 50% decrease in melanoma mortality [8]. Females reported being approximately twice
as likely to be aware of their skin and any problems. However, once a lesion
was noticed, there was no difference by sex in the delay to seeing a clinician
[105].
Brady et al, showed that women were more likely to self-detect melanoma
lesions than men [13]; others have shown that women are also more aware of
their skin [107] and more likely to utilize sunscreen [60, 84].

3.2.6

Sun Exposure

Ultraviolet radiation, including both sun exposure and tanning bed use has been
clearly and definitively associated with the development of melanoma by the
International Agency for Cancer Research [30]. There are different types of
sun exposure with “intermittent” sun exposure, the type of exposure one gets
on weekends after being inside all week, often leading to sunburns, considered
the major type of sun exposure associated with the development of melanoma
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[3]. This type of sun exposure is in contrast to chronic exposure, the type of sun
exposure received on an almost daily basis, such as in occupation or gardening.
Chronic exposure, in meta-analyses, does not increase the risk of melanoma
[38].
The incidence pattern for melanoma differs dramatically be age and sex (Figure 3.1), such that females have a slightly higher rate of melanoma until around
the age of 50 and then the incidence increases slowly while male incidence increases dramatically at that point(SEER*Explorer: An Interactive Website for
SEER Cancer Statistics [Internet]. Surveillance Research Program, National
Cancer Institute. [Cited 2017 Apr 14]. Available from Https://Seer.Cancer.Gov/Explorer/.,
n.d.). Further, the anatomic site of melanoma differs by sex. These differences
are consistent across latitudes. Males tend to have the highest incidence of
melanoma on the trunk and a higher incidence of melanoma on the head and
neck than females. Females have a high incidence of melanoma on the leg. It
is not clear whether these differences are a function of sun exposure patterns, a
genetically controlled sex-linked characteristic, or a combination of both.
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Figure 3.1: Melanoma of the skin incidence. Source: SEER 13 areas (San Francisco, Connecticut,
Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska
Native Registry and Rural Georgia). Rates are age-adjusted as appropriate to the 2000 US Std
Population (19 age groups - Census P25-1103).

Gordon et al, analysed sun exposure data from Stockholm-Gotland healthcare
region (average population 1.7 million), representing 20% of the Swedish population during the time period 1977 to 2001 [46]. Their data demonstrates
clearly that males received more UV radiation (intermittent overall and intermittent on the core) than females. This is in contrast to the lack of a difference between the sexes for ultraviolet radiation on the extremities (peripheral)
and chronic. Such information underlines the differences between intermittent
sun exposure and chronic exposure and their respective risks for developing
melanoma.
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3.2.7

Sun Protection

It is important to evaluate the association between sunscreen and other sun
protection methods in reducing melanoma risk. The most persuasive evidence
for the use of sunscreens comes from a randomized clinical trial conducted in
Queensland, Australia [47].
A National Health Interview Survey interviewed a representative sample of
31,162 US adults in 2015. It appears that females generally use more sun
protection than males (shade, sunscreen and sun avoidance). However, males
appeared to use more clothing in the sun [60].
A large systematic review and meta-analysis involving 313,731 participants,
10,813 cases or non-melanoma skin cancer 857 cases found no association between the use of sunscreen and the development of melanoma,[130]. A contradictory study by Rueegg et al, found protective associations for use of sunscreen in hospital-based studies, one ecological study and a randomized controlled trial [122]. However, population-based cases control and cohort studies
found significant positive associations between the use of sunscreen and the
development of melanoma. A case-control study of more than 1,000 participants in Minnesota also evaluated the use of sunscreens and other methods of
sun protection and found that sunscreens were associated with a reduced risk
of developing melanoma but that other sun protection methods, such as seeking
shade and using clothing were far stronger in their association with a reduced
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risk of melanoma [84].

3.3

Conclusion

Despite major progress in melanoma research in the development of immunotherapy, understanding the relationship between mutational loads and the immune
system, and the rich literature documenting marked sex differences in immunocompetence, hormones, and genetics in melanoma, sex disparities in survival
persist. Although there are multiple differences between men and women in
terms of behavior in the sun and in utilization of primary care, it is unclear
whether these behaviors would add up to the strong differences seen in survival
between males and females. It seems much more likely that the biological
differences are critical in terms of developing advanced melanoma and that
more investigation of these is needed. Biological sex is a fundamental factor in
melanoma. It is critical that future studies be powered sufficiently to account
for sex differences. These sex disparities in melanoma outcomes provide an
excellent opportunity to test clear hypotheses and to develop new insights into
the underlying mechanisms of melanoma, cancer, and the immune system.
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Chapter 4
TUMOR MUTATIONAL BURDEN IN EARLY-STAGE MELANOMA

4.1

Chapter Abstract

Background: Tumor Mutational Burden (TMB) is a promising new biomarker
for immunotherapy success. Patients with high TMB have a better prognosis
than patients with low TMB. Among melanoma patients, there is a sex specific
pattern to TMB, late-stage and metastatic tumors in men have a higher TMB
when compared with women. It is unclear whether this relationship extends to
early-stage primary tumors.
Methods: Here we evaluate the relationship between sex and Tumor Mutational Burden (TMB) in 288 Stage IIA-IIID primary tumors. The sample includes 66 superficial spreading (24.5%), 32 nodular (11.9%), 14 lentigo ma42

ligna (5.2%), 126 Not Otherwise Specified (46.8%), and 31 Other (11.5%).
Over 38% of the tumors are ulcerated and 49.1% of melanomas are greater
than 4.0 mm thick (median Breslow thickness of all = 4mm). Tumors varied by
site: 28.8% of the tumors are in the head and neck, 23.3% on the trunk, 14.9%
in the upper extremities, 32.6% in the lower extremities, and 0.3
Results: After controlling for the effects of age at diagnosis and sex, four
pathologic variables showed significance: stage, tumor site, histologic subtype, and elastosis. In the full multivariable logistic model sex (referent: Female, multivariable OR=0.48, 95% CI=0.25 to 0.91, P = 0.02), mild to moderate solar elastosis (referent: Absent, multivariable OR=4.7, 95% CI=2.3 to
9.5, p =< 0.001), and severe solar elastosis (referent: Absent, multivariable
OR=5.2, 95% CI=2.5 to 10.8, p =< 0.001) were significantly associated with
high TMB.
Conclusions: In a cross-sectional study of 288 early stage primary melanoma
tumors, only biological sex and solar elastosis predicted TMB. Men are more
likely to have high TMB women compared to women. This analysis is the first
to investigate the relationship between sex and TMB in an early-stage primary
tumors. Future studies should focus on the role of sex, TMB, and solar elastosis
in melanoma-specific survival.
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4.2

Introduction

The female survival advantage in cutaneous malignant melanoma is robust,
consistent, and well-documented [27, 121]. Melanoma mortality is higher in
men than women [33], melanoma tumors in women have a longer delay before
relapse, are less likely to progress to lymph nodes, and less likely to metastasize
[67, 66, 127].
Recent breakthroughs in immunotherapy have been especially successful for
patients with melanoma. Despite these successes, it is unclear why some patients respond to immunotherapy while others do not. Tumor Mutational Burden (TMB), a simple count of missense mutations divided by the number of
sequenced nucleotides in tumor cells [16], is a promising new biomarker for
immunotherapy success. Patients with high TMB have a better prognosis than
patients with low TMB. Interestingly, among melanoma patients, there is a sex
specific pattern to TMB.
Despite a poorer overall prognosis, men have a higher TMB when compared
with females [27, 121, 50]. This raises an interesting question, if high TMB is
associated with a better outcome, why is it more likely to be found in males?
A study by Gupta and colleagues [50] evaluated sex, TMB, and melanoma
specific survival in metastatic melanomas using The Cancer Genome Atlas
(TCGA) dataset (8,9). is unclear whether this relationship extends to primary
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tumors or early stage tumors, both of which are have high clinical relevance.
Here we will evaluate sex differences in the mutational profiles of 288 early
stage tumors from melanoma patients naı̈ve to immunotherapy. Understanding
this relationship will help elucidate the role of biological sex and TMB, creating
new possibilities for targeted therapy. This analysis will be a promising first
step in investigating the relationship between biological sex and melanoma.

4.3
4.3.1

Methods
Data Collection

Our sample consists of 288 primary melanoma tumors, stages IIA-IIID (AJCC
8th edition), procured by the InterMEL (P01CA206980, PI: Berwick) from the
following Centers: Case Western Reserve University, Cleveland Clinic Foundation, Dartmouth University, MD Anderson Cancer Center, Melanoma Institute of Australia, Memorial Sloan Kettering Cancer Center, New York University, University of North Carolina, Yale University, and Roswell Park Cancer
Institute. All patients were treated using standard-of-care surgery but no immunotherapy.
All tumors were assessed for eligibility and have adequate tumor tissue and
germline or normal DNA. Eligibility included having a primary cutaneous
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melanoma diagnosed on or after January 1998 and before January 1, 2014.
Tumors used the metrics of the AJCC8th edition, so that they could not be <
1.0 mm and rounded up; they had to be at least 1.05 mm. The tumor must have
been a first primary melanoma. The patient could not have received adjuvant
immunotherapy or targeted therapy.
Demographic information was extracted at each site and clinical and pathologic information was recorded initially by site pathologists to determine eligibility, FFPE tumors were sent on to the Memorial Sloan Kettering (MSK)
Molecular Epidemiology Laboratory for nucleic acid (NA) extraction and the
Dermatopathology service for pathological assessment (KB and CL). After NA
extraction, DNA was sent to the FDA-approved MSK-IMPACT laboratory for
sequencing of 468 actionable targets [155].
Tumors were sequenced with the MSK IMPACTTM platform. Bioinformatic
analysis [17] clinical and laboratory workflows [155], and mutation calling
pipelines [17] have been described previously. Synonymous mutations, genes
without Entrez IDs, intronic splice region mutations, splice region variants in
non-coding genes, and all non-coding events were all removed before analysis.
Tumor mutational burden (TMB) is defined as the number of missense mutations per megabase [16]. High TMB is defined as => 20 mutations per mb
[16]. TMB in targeted gene panel assays have 98% correspondence with whole
exome sequencing [16]. Tumors were grouped according the TCGA classifi46

cation: BRAF, NRAS, NF1 and Triple Wildtype. The TERT mutation in the
promoter region also assessed.

4.3.2

Statistical Analysis

Summary statistics were used to describe the patient demographic and tumor
characteristics by sex and by tumor mutation burden. To estimate the effects
of the variables of interest and their association with TMB, we conducted separate logistic regressions. Odds ratios and 95% confidence intervals were calculated using the R epiDisplay package to measure the magnitude of association. p − values were calculated using Wald tests to estimate the statistical
significance. Because tumor mutations increase over time, we adjusted for age
at diagnosis in addition to sex. Multivariable logistic regression model with
backwards selection was used to estimate the intendent effects of the variables
of interest. Statistical significance was p < 0.05. All analyses were conducted
with R v4.0.2.

4.3.3

Human Subjects Approvals

Institutional IRB approval was granted for all protocols in accordance with
guidelines set by the Institutional Review Boards of the University of New
Mexico (UNM HRCC #16-389). Stored tumor samples and nucleic acids contain no identifying data.
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4.4

Results

Our study has a total 177 males with a median age of 65 and 111 (38.5%)
females with a median age of 59. Fifty-two percent of tumors are stages IIA-D.
The histologic subtypes of the tumors are 24.5% superficial spreading, 11.9%
nodular, 5.2% lentigo maligna, 46.8% not otherwise specified, and 11.5% other.
Ulceration was present in 38.7% of the tumors showed ulceration and there
are 49.1 percent of melanomas greater than 4.0 mm thick (median Breslow
thickness of all = 4mm) melanomas. While a small percentage of the tumors
had brisk (2.2%) TILs, a large percentage had non-brisk (86.2%) TILs. Tumors
varied by site; 28.8% of the tumors are in the head and neck, 23.3% on the
trunk, 14.9% in the upper extremities, 32.6% in the lower extremities, and
0.3% other. Over 45% of the tumors have solar elastosis. Overall, 58.7% of the
tumors have TERT mutations, 42% have BRAF mutations, 17.3% have NRAS
mutations, 26.9% have NF1 mutations, and 24.7% have the triple wildtype
mutation.

Table 4.1: Clincopathologic characteristics of 288 early stage melanoma tumors grouped by sex.

n

Continued on next page
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Males

Females

177

111

p

Table 4.1 – continued from previous page
Males
Females
p
Age at Diagnosis (median [IQR])
65 [55, 77]
59 [44, 73.5] <0.001
Tumor Characteristics
Stage(AJCC8)
IIAB
IIC
IIIAC
IIID
Site
Head and Neck
Trunk
Upper Extremities
Lower Extremities
Other
Initial Breslow Thickness (median [IQR])
Breslow Thickness(mm)
<1
1.01-2
2.01-4
4+
Not assessable/missing
Histology
Superficial Spreading
Nodular
Acral Lentiginous
Lentigo Maligna
Not otherwise specified
Other
Not assessable/missing
Ulceration

Continued on next page
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74 (41.8)
22 (12.4)
72 (40.7)
9 (5.1)

41 (36.9)
13 (11.7)
52 (46.8)
5 (4.5)

58 (32.8)
47 (26.6)
28 (15.8)
44 (24.9)
0 (0.0)
4.1 [2.7, 6.5]

25 (22.5)
20 (18.0)
15 (13.5)
50 (45.0)
1 (0.9)
0.005
3.85 [2.5, 6.] 0.26

0 ( 0.0)
17 ( 9.6)
71 (40.1)
89 (50.3)
1

1 ( 0.9)
19 ( 17.3)
38 ( 34.5)
52 ( 47.3)
0

0.14

34 (20.0)
25 (14.7)
6 (3.5)
11 (6.5)
81 (47.6)
13 (7.6)
7

32 (32.3)
( 7.1)
3 (3.0)
3 (3.0)
45 ( 45.5)
9 ( 9.1)
12

0.12

0.78

Table 4.1 – continued from previous page
Males
Females
Present
69 (42.9)
30 (31.6)
Absent
92 (57.1)
65 (68.4)
Not assessable/missing
16
16

p

0.1

TILs
Brisk
Non brisk
Absent
Not assessable/missing
Mitotic Index (mm)
0-2
3-4
5-8
9+
Not assessable/missing
Solar Elastosis
Severe
Mild/Moderate
Absent
Not assessable/missing

4 (2.4)
141 (83.9)
23 (13.7)
9

2 ( 2.0)
90 (90.0) )
8 ( 8.0)
11

0.35

58 (34.1)
43 (25.3)
30 (17.6)
39 (22.9)
7

43 ( 42.2)
23 ( 22.5)
14 ( 13.7)
22 (21.6)
9

0.58

45 (29.6)
32 (21.1)
75 (49.3)
25

11 ( 12.2)
22 ( 24.4)
57 ( 63.3)
21

0.008

18 [10, 39]

12 [6, 21.75] <0.001

72 (41.6)
101 (58.4)
4

26 ( 23.6)
84 (76.4)
1

0.003

72 (41.6)
101 (58.4)
4

47 ( 42.7)
63 (57.3)
1

0.95

Mutational Status
Total number of mutations (median [IQR])
Tumor Mutational Burden
High
Low
Not assessable/missing
BRAF
Present
Absent
Not assessable/missing
NRAS

Continued on next page
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Table 4.1 – continued from previous page
Males
Females
Present
31 (17.9)
18 ( 83.6)
Absent
142 (82.1)
92 (82.9)
Not assessable/missing
4
1

p

0.86

NF1
Present
Absent
Not assessable/missing
Triple Wildtype
Present
Absent
Not assessable/missing
TERT
Present
Absent
Not assessable/missing

48 (27.7)
125 (72.3)
4

28 (25.5)
82 (74.5)
1

0.78

45 (26.0)
128 (74)
4

25 (22.7)
85 (77.3)
1

0.63

110 (64.4)
63 (35.6)
4

56 (51.4)
54 (48.6)
1

0.05

There are significant sex differences in age at diagnosis, stage, tumor site, solar
elastosis, TMB, number of total mutations, and the TERT mutation (Table 4.1).
Males have significantly later median age at diagnosis (65 years) than females
(59 years, p < 0.001) and a higher percentage of tumors on the head and neck
trunk and upper extremities. Males are also more likely to have solar elastosis
than females (Table 4.1). Males have a significantly higher number of total
mutations (18 vs. 12, p < 0.001) and TERT mutations than females (Table
4.1). There are no sex differences in stage, Breslow thickness, tumor histology,
ulcerations, mitotic index, or the presence of tumor infiltration lymphocytes
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(TILs). There are significant differences in tumor site by both sex (p = 0.005)
and TMB (p = 0.001).

Table 4.2: Demographic, Clinical, Tumor Characteristics of 288 Tumors stratified by Tumor Mutational Burden (TMB)

Males
n
SEX - Females
Age at Diagnosis (median [IQR])

Females

p

185
98
84 (45.4)
26 (26.5)
60 [48, 74] 70 [58, 78]

0.003
<0.001

60 (32.4)
19 (10.3)
95 (51.4)
11 (5.9)

52 (53.1)
16 (16.3)
27 (27.6)
3 (3.1)

0.001

38 (20.5)
46 (24.9)
23 (12.4)
77 (41.6)
1 (0.5)
4 [2.5, 6.2]

45 (45.9)
20 (20.4)
20 (20.4)
13 (13.3)
0 (0.0)
4.3 [3, 6.5]

0.001
0.16

1 ( 0.5)
28 (15.1)
68 (36.8)
88 (47.6)
0

0 (0.0)
8 (8.2)
38 (39.2)
51 (52.6)
1

0.35

Tumor Characteristics
Stage(AJCC8)
IIAB
IIC
IIIAC
IIID
Site
Head and Neck
Trunk
Upper Extremities
Lower Extremities
Other
Initial Breslow Thicknes (median [IQR])
Breslow Thickness (mm)
<1
1.01-2
2.01-4
4+
Not assessable/missing

Continued on next page
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Table 4.2 – continued from previous page
Males
Females
Histology
Superficial Spreading
Nodular
Acral Lentiginous
Lentigo Maligna
Not otherwise specified
Other
Not assessable/missing
Ulceration
Present
Absent
Not assessable/missing
TILs
Brisk
Non brisk
Absent
Not assessable/missing
Mitotic Index (mm)
0-2
3-4
5-8
9+
Not assessable/missing
Solar Elastosis
Absent
Mild/Moderate
Severe/Cannot.assess
Not assessable/missing

p

49 (28.7)
16 (9.4)
8 (4.7)
5 (2.9)
82 (48)
11 ( 6.4)
14

16 (17.0)
16 (17.0)
0 (0.0)
9 ( 9.6)
42 (44.7)
11 (11.7)
4

0.003

60 (36.6)
104 (63.4)
21

38 ( 43.2)
50 (56.8)
10

0.37

5 (2.9)
146 (85.4)
20 (11.7)
14

1 ( 1.1)
81 ( 87.1)
11 (11.8)
5

0.63

63 (36.4)
44 (25.4)
28 (15.1)
38 (22.0)
12

37 ( 38.9)
15 (15.8)
15 (15.3)
23 (24.2)
3

0.86

104 (68.0)
26 (17.0)
23 (15.0)
32

24 (28.2)
28 (32.9)
33 (38.8)
13

<0.001

Mutational Status
Total number of mutations (median [IQR]) 11 [6, 16]

Continued on next page
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46 [33, 75.8] <0.001

Table 4.2 – continued from previous page
Males
Females
BRAF
Present
Absent
NRAS
Present
Absent
NF1
Present
Absent
Triple Wildtype
Present
Absent
TERT
Present
Absent

p

82 (44.3)
103 (55.7)

37 (37.8)
61 (62.2)

0.35

28 (15.1)
157 (84.9)

21 (21.4)
77 (78.6)

0.24

22 (11.9)
163 (88.1)

54 ( 55.1)
44 (44.9)

<0.001

60 (32.4)
125 (67.6)

10 (10.2)
88 (89.8)

<0.001

88 (47.6)
97 (52.4)

78 (79.6)
20 (20.4)

<0.001

Of the 288 tumors, 98 (34%) of have a high TMB (Number of mutations
≥20/mb). When comparing high TMB with low TMB groups (Table 4.2), there
are significant differences in sex, age at first diagnosis, stage, tumor site, tumor
histology, solar elastosis, NF1, Triple wildtype and TERT mutations (Table
4.2).
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Table 4.3: Logistic regression of Mutational Burden (TMB) on four variables after accounting for
the effects of sex and age of diagnosis.

OR (95% CI)

p

Stage (AJCC 8) : ref=IIAB
IIC
IIIAC
IIID

0.9 (0.4, 2.0)
0.4∗∗∗ (0.2, 0.7)
0.3 (0.1, 1.3)

0.85
<0.001
0.12

Site: ref= Head and Neck
Lower Extremities
Upper Extremities
Trunk

0.2∗∗∗ (0.1, 0.3)
0.7 (0.3, 1.5)
0.4∗∗ (0.2, 0.8)

<0.001
0.40
0.01

Histology: ref=Superficial Spreading
Lentigo Maligna
Nodular
Other
Not otherwise specified

4.1∗ (1.2, 14.5)
2.9∗ (1.1, 7.3)
1.8 (0.7, 4.6)
1.5 (0.7, 2.9)

0.03
0.03
0.24
0.3

Solar Elastosis: ref=Absent
Mild/Moderate
Severe

4.7∗∗∗ (2.3, 9.5) <0.001
5.2∗∗∗ (2.5, 10.8) <0.001
∗

Note:

p<0.05; ∗∗ p<0.01; ∗∗∗ p<0.001

After controlling for the effects of sex and age, tumors staged AJCC8 IIA-C,
tumors in the lower extremities and trunk, tumors with the lentigo maligna and
nodular histologic type, and tumors with mild to severe solar elastosis were
significantly associated with TMB (Table 4.3).
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In the full multivariable logistic model containing sex, age, stage, site, histologic subtype, and solar elastosis, only tumors stages IIA-C and solar elastosis
were significantly associated with TMB (4.4).

Table 4.4: Final Multivariable Models

Sex: Females

Full Model
0.6 (0.3, 1.2)

Reduced Model
0.48∗ (0.25, 0.91)

Age at Diagnosis

1.0 (0.98,1.02)

1.0 (0.99, 1.03)

Stage (AJCC 8) : ref=IIAB
IIC
IIIAC
IIID

1.0 (0.4, 2.5)
0.4∗∗ (0.2, 0.8)
0.8 (0.2, 3.5)

0.7 (0.3, 1.96)
0.5 (0.2, 1.0)
0.6 (0.1, 3.3)

Site: ref=Head and Neck
Lower Extremities
Upper Extremities
Trunk

0.4 (0.2, 1.0)
1.2 (0.5, 3.1)
1.0 (0.4, 2.5)

Histology: ref=Superficial Spreading
Lentigo Maligna
Nodular
Other
Not otherwise specified

2.0 (0.5,8.9)
2.5 (0.9, 6.8)
0.7 (0.2, 2.4)
1.5 (0.7,3.3)

Solar Elastosis: ref=Absent
Mild/Moderate
Severe

3.5∗∗∗ (1.6, 7.5) 4.7∗∗∗ (2.3, 9.5)
3.5∗∗ (1.4, 8.8) 5.2∗∗∗ (2.5, 10.8)

Continued on next page
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Table 4.4 – continued from previous page
Full Model
Reduced Model
Observations
Log Likelihood
Akaike Inf. Crit.

234
−123.8
280
∗

Note:

238
−134
278.7

p<0.05; ∗∗ p<0.01; ∗∗∗ p<0.001

In the final multivariable model, after accounting for the effect of age at diagnosis, variables significantly associated with a high TMB were sex (referent:
Female, multivariable OR=0.48, 95% CI=0.25 to 0.91, p = 0.02), mild to
moderate solar elastosis (referent: Absent, multivariable OR=4.7, 95% CI=2.3
to 9.5, p ≤ 0.001), and severe solar elastosis (referent: Absent, multivariable
OR=5.2, 95% CI=2.5 to 10.8, p ≤ 0.001).

4.5

Discussion

The results suggest sex and solar elastosis are associated with TMB. Males
have a higher tumor mutational burden than females in early stage (IIA-IIID)
primary melanoma tumors and severe solar elastosis is associated with high
TMB.
Solar elastosis is a well-known marker of UV exposure [40, 141], however little
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is known about its relationship to TMB. The link between solar elastosis and
TMB possibly connects TMB to a dose relationship with UV exposure. If so,
we expect TMB and solar elastosis to cluster with tumor site, specifically in
head and neck and the upper extremities. Given the relationship between high
TMB and survival and solar elastosis and survival [8, 9, 4, 58], sex, TMB, and
solar elastosis should be evaluated in the context of survival.
Another possibility is that solar elastosis and TMB are generated by mutational
events independent of UV exposure. Tumors with severe solar elastosis often
present at later ages and solar elastosis is associated with age. Future studies
should evaluate TMB and solar elastosis, in the context of melanoma-specific
survival.
Our study is the first to investigate the relationship between sex and tumor
mutational burden in an early stage primary cohort that has not received immunotherapy. Our results are an important first step to increasing our understanding of the relationship between mutational burden, survival, and biological sex.
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Chapter 5
CONCLUSION

Here we explored sex differences in two age-related diseases, tooth loss and
melanoma. Our evaluation of tooth loss as a potential cost of female reproduction is the first large-scale study of tooth loss in the Tsimane and is the first
to evaluate tooth loss and parity in a large sample of natural fertility foragerhorticulturists. The Tsimane have an extreme burden of dental pathology across
age and sex. Tooth loss seems to be accelerated within Tsimane females. While
the higher rate of tooth loss in Tsimane females is consistent with many other
studies, but the reasons for it are obscure. As hypothesized, we found that after
accounting for the effect of age and toothbrushing, the number of children increases tooth loss within Tsimane females but not Tsimane males. While tooth
loss is a cost of reproduction specific to females, parity explains very small
amount of the variation, accounting for approximately 1.2% of the variation
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in tooth loss. Because the extreme tooth loss across age and sex and because
parity accounts for a little variation in tooth loss, we conclude that among the
Tsimane teeth are not a major cost of female reproduction. Other factors likely
overwhelm parity in their effects on tooth loss in Tsimane females. An unanticipated, but important finding of this study is the high frequency of tooth loss in
Tsimane across age and sex. This is likely to have long-term consequences for
the Tsimane as they become more immersed in a market economy. Behavioral
factors such as tooth extraction and chicha production should be evaluated in
future studies.
A recent paper has described the Tsimane as having the ‘healthiest hearts in the
world’; the Tsimane have excellent overall cardiovascular health across age and
sex, with virtually no cardiovascular disease (CVD)[69]. However, tooth loss is
a predictor of both CVD and future CVD-associated mortality [61, 63, 68, 98,
101, 108]. An emerging literature proposes the use of tooth loss as a possible
upstream predictor of future cardiometabolic disease. If correct, the Tsimane
are facing an impending health crisis. Future studies should focus on additional
factors upstream of tooth loss and include multi-level health interventions and
assessments of cardiometabolic markers.
In contrast to tooth loss, where females experience a higher burden of disease,
females have a lower burden of TMB and better survival outcomes in melanoma
when compared to males. We show that males have a higher TMB than females
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in early stage (IIA-IIID) primary melanoma tumors. We hypothesize that the
large antigenic signatures of tumors with high TMB are more likely to targeted
by the immune system. Because of sex biases in immunosurveillance, high
TMB tumors are more likely to be eliminated by females. This would explain
why males have higher TMB despite a poor prognosis compared to females.
An additional finding of the study is an association between solar elastosis
and high TMB. A well-known marker of UV exposure, solar elastosis possibly
connects TMB with sun exposure behaviors [141, 40]. If UV exposure drives
TMB, we expect TMB and solar elastosis to cluster with tumor site, specifically
in head and neck and the upper extremities. Because TMB is associated with
improved prognosis, we also expect an association between melanoma specific
survival and the presence of elastosis. Future studies should evaluate TMB,
elastosis, in melanoma-specific survival and should include the evaluation of
tumor mutational signatures. Our study is the first to investigate the relationship
between sex and tumor mutational burden in an early stage primary cohort that
has not received immunotherapy. Future studies should include measures of
sun exposure and survival.
These studies are important first steps towards increasing our understanding the
role of biological sex in two age-related disease outcomes, tooth loss and TMB
in melanoma.
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